ERBB2 and breast carcinoma: Another group, using a MMTV-Her2 breast cancer model, showed that Her2 mediated suppression of the p38-MK2-HSP27 signaling axis facilitated early tumor cell dissemination and metastases through activation of the β-catenin pathway.